Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas [SBIR (R43/R44)]

The summary for the Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas [SBIR (R43/R44)] grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas [SBIR (R43/R44)]: This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress toward integrated long term glucose regulated insulin/pancreatic hormones delivery systems (artificial pancreas).

Federal Grant Title:	Small Business Innovation Research to Develop New Therapeutics and Monitoring Technologies for Type 1 Diabetes (T1D) Towards an Artificial Pancreas [SBIR (R43/R44)]
Federal Agency Name:	National Institutes of Health
Grant Categories:	Food and Nutrition Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-DK-13-001
Type of Funding:	Grant
CFDA Numbers:	93.286
CFDA Descriptions:	Discovery and Applied Research for Technological Innovations to Improve Human Health
Current Application Deadline:	Mar 06, 2013
Original Application Deadline:	Mar 06, 2013
Posted Date:	Dec 17, 2012
Creation Date:	Dec 17, 2012
Archive Date:	Apr 06, 2013
Total Program Funding:	$2,500,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Grant Announcement Contact: NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]]
Similar Government Grants: • New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Opt...; • Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historic...; • Understanding and Mitigating Health Disparities experienced by People with Disabilities ca...; • National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Op...; • Research on Bioethical Issues Related to Bionic and Robotic Device Development and Transla...; • Exploratory Grants (P20) for NIBIB Quantum Projects; • Nibib Research Supplements to Promote Clinical Resident Research Experiences; • Innovation in Molecular Imaging Probes
More Grants from the National Institutes of Health: • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...; • NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and C...; • Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed...; • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Am...